Evidence map›Paper›PMID 31640741›Full record

ArticleBMC oral health2019

Impact of toothpaste on oral health-related quality of life in people with dentine hypersensitivity.

Stephen Mason, Gary R Burnett, Nisha Patel, Avinash Patil, Robert Maclure

3 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in BMC oral health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02752958 nacompletednot on this map

Study to Investigate the Impact on Oral Health Related Quality of Life of Managing Dentine Hypersensitivity With a Daily Use Anti-Sensitivity Toothpaste

TypeinterventionalSponsorGlaxoSmithKlineRan2016 to 2017Enrolled75ConditionsDentin SensitivityArmsstannous fluoride
NCT04887181 nacompletednot on this mapstarted 2020, after this paper: background citation

The Effects of Different Dentin Hypersensitivity Treatment Methods on Quality of Life

TypeinterventionalSponsorKırıkkale UniversityRan2020 to 2021Enrolled69ConditionsDentin HypersensitivityArmsTeethmate Desensitizer, Gluma Desensitizer, Hybrid Bond
NCT06216262 nacompletednot on this mapstarted 2024, after this paper: background citation

Evaluation of the Effectiveness of Home-Use Desensitizing Agents on Dentin Hypersensitivity

TypeinterventionalSponsorÇanakkale Onsekiz Mart UniversityRan2024 to 2024Enrolled180ConditionsDentin SensitivityArmsControl group, Arginine, Novamin, Propolis, Casein Phosphopeptide Amorphous Calcium Phosphate
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Stephen MasonGSK Consumer Healthcare, St George's Avenue, Weybridge, Surrey, KT13 0DE, UK. stephen.x.mason@gsk.com.ORCID 0000-0002-3841-2313
Gary R BurnettGSK Consumer Healthcare, St George's Avenue, Weybridge, Surrey, KT13 0DE, UK.
Nisha PatelGSK Consumer Healthcare, St George's Avenue, Weybridge, Surrey, KT13 0DE, UK.
Avinash PatilSyneos Health, Commerzone, Building No. 4, 6th Floor, Survey No. 144/145, Samrat Ashok Path, Yerwada Jail Road, Pune, 411006, India.
Robert MaclureIntertek CRS Ltd., 119 Station Road, Ellesmere Port, Cheshire, CH65 4BW, UK.
Age UK · GBIntertek (United Kingdom) · GBSyneos Health (India) · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDentine hypersensitivity can impact functional status and everyday activities such as eating and talking. This study aimed to assess changes in oral health-related quality of life measures in individuals with dentine hypersensitivity following long-term use (24 weeks) of a commercially available toothpaste marketed for dentine hypersensitivity relief.

methodsThis study was conducted across two sites and enrolled 75 adults with ≥2 non-adjacent sensitive teeth. Participants were assigned to twice-daily brushing with toothpaste containing 0.454% w/w stannous fluoride (1100 ppm fluoride). Every 4 weeks, participant-reported outcomes were assessed using the Dentine Hypersensitivity Experience Questionnaire (DHEQ), a condition specific oral health-related quality of life scale that has five domains and includes questions on social and emotional impact, restrictions, adaptations and effect on life overall. Responses to a clinically applied evaporative (air) stimulus were assessed using the examiner-observed Schiff sensitivity scale and Labelled Magnitude Scales (LMS), which included dentine hypersensitivity-specific descriptors of intensity, duration, tolerability and descriptive qualities of the participant's response.

resultsParticipant-reported outcomes demonstrated reduction of the impact of dentine hypersensitivity over time on health-related quality of life, as measured by the DHEQ. This reached statistical significance from Week 8 onwards (p < 0.0001 versus baseline) for the Total DHEQ score, with scores continually decreasing at each timepoint. Most domain scores followed a similar pattern. Statistically significant reductions were also detected for the examiner-observed Schiff Sensitivity Scale scores at all timepoints (including at 4 weeks) (p < 0.05), which were mirrored by LMS responses. The toothpaste was generally well-tolerated.

conclusionsThese results show that long-term use of a sensitivity toothpaste containing 0.454% w/w stannous fluoride has a beneficial, ongoing, impact on the oral health-related quality of life of people with dentine hypersensitivity.

trial registrationThis study was registered at Clinicaltrials.gov ( https://clinicaltrials.gov/ct2/show/NCT02752958 ) on April 27, 2016.

Indexed as

Dentin Desensitizing AgentsDentin SensitivityOral HealthQuality of LifeToothpastesAdultFluoridesHumansSodium FluorideTreatment OutcomeDentin Desensitizing AgentsFluoridesSodium FluorideToothpastesDentinDentin sensitivityPainPatient reported outcome measuresTin fluoride

Identifiers

PMID31640741
PMCPMC6805594
OpenAlexW2982108905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.